# Post Holdings, Inc.: overview

POST · NYSE · CIK 1530950 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/post.md) · [Financials](/companies/post/financials.md) · [Filings](/companies/post/filings.md) · [Insiders](/companies/post/insiders.md)

Latest reported revenue: [$1.95bn](/filings/0001530950-26-000077.md) for Q3 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001530950-26-000077).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,010 d](/filings/0001530950-25-000260.md) | [1,975](/filings/0001530950-26-000020.md) | [1,952](/filings/0001530950-26-000057.md) | [1,984](/filings/0001530950-26-000077.md) | [2,247 d](/filings/0001530950-25-000260.md) | [2,175](/filings/0001530950-26-000020.md) | [2,043](/filings/0001530950-26-000057.md) | [1,948](/filings/0001530950-26-000077.md) |
| Gross margin | % | [28.6% d](/filings/0001530950-25-000260.md) | [30.1%](/filings/0001530950-26-000020.md) | [28.0%](/filings/0001530950-26-000057.md) | [30.0%](/filings/0001530950-26-000077.md) | [26.8% d](/filings/0001530950-25-000260.md) | [29.4%](/filings/0001530950-26-000020.md) | [30.2%](/filings/0001530950-26-000057.md) | [29.1%](/filings/0001530950-26-000077.md) |
| Operating margin | % | [9.5% d](/filings/0001530950-25-000260.md) | [10.8%](/filings/0001530950-26-000020.md) | [9.3%](/filings/0001530950-26-000057.md) | [11.8%](/filings/0001530950-26-000077.md) | [7.5% d](/filings/0001530950-25-000260.md) | [11.0%](/filings/0001530950-26-000020.md) | [10.4%](/filings/0001530950-26-000057.md) | [9.7%](/filings/0001530950-26-000077.md) |
| Net margin | % | [4.1% d](/filings/0001530950-25-000260.md) | [5.7%](/filings/0001530950-26-000020.md) | [3.2%](/filings/0001530950-26-000057.md) | [5.5%](/filings/0001530950-26-000077.md) | [2.3% d](/filings/0001530950-25-000260.md) | [4.5%](/filings/0001530950-26-000020.md) | [4.0%](/filings/0001530950-26-000057.md) | [3.3%](/filings/0001530950-26-000077.md) |
| Diluted EPS | $ per share | not reported | [1.78](/filings/0001530950-26-000020.md) | [1.03](/filings/0001530950-26-000057.md) | [1.79](/filings/0001530950-26-000077.md) | not reported | [1.71](/filings/0001530950-26-000020.md) | [1.56](/filings/0001530950-26-000057.md) | [1.29](/filings/0001530950-26-000077.md) |
| Free cash flow | $m | [96.2 d](/filings/0001530950-25-000260.md) | [171](/filings/0001530950-26-000020.md) | [70.2 d](/filings/0001530950-26-000057.md) | [94.9 d](/filings/0001530950-26-000077.md) | [152 d](/filings/0001530950-25-000260.md) | [119](/filings/0001530950-26-000020.md) | [151 d](/filings/0001530950-26-000057.md) | [131 d](/filings/0001530950-26-000077.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,981](/filings/0001530950-23-000350.md) | [5,851](/filings/0001530950-24-000365.md) | [6,991](/filings/0001530950-25-000260.md) | [7,923](/filings/0001530950-25-000260.md) | [8,158](/filings/0001530950-25-000260.md) |
| Gross margin | % | [28.7%](/filings/0001530950-23-000350.md) | [25.1%](/filings/0001530950-24-000365.md) | [26.9%](/filings/0001530950-25-000260.md) | [29.1%](/filings/0001530950-25-000260.md) | [28.7%](/filings/0001530950-25-000260.md) |
| Operating margin | % | [9.8%](/filings/0001530950-23-000350.md) | [7.1%](/filings/0001530950-24-000365.md) | [8.6%](/filings/0001530950-25-000260.md) | [10.0%](/filings/0001530950-25-000260.md) | [9.8%](/filings/0001530950-25-000260.md) |
| Net margin | % | [3.3%](/filings/0001530950-23-000350.md) | [12.9%](/filings/0001530950-24-000365.md) | [4.3%](/filings/0001530950-25-000260.md) | [4.6%](/filings/0001530950-25-000260.md) | [4.1%](/filings/0001530950-25-000260.md) |
| Diluted EPS | $ per share | [2.38](/filings/0001530950-23-000350.md) | [12.09](/filings/0001530950-24-000365.md) | [4.82](/filings/0001530950-25-000260.md) | [5.64](/filings/0001530950-25-000260.md) | [5.51](/filings/0001530950-25-000260.md) |
| Free cash flow | $m | [397](/filings/0001530950-23-000350.md) | [127](/filings/0001530950-24-000365.md) | [447](/filings/0001530950-25-000260.md) | [502](/filings/0001530950-25-000260.md) | [488](/filings/0001530950-25-000260.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/post/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $347.2m | 3,933,480 |  | Reduced −46,322 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $278.6m | 3,156,637 |  | Added +84,762 |
| [Route One Investment Company, L.P.](/funds/1512171.md) | 2026-06-30 | $260.4m | 2,950,568 |  | Unchanged |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $220.5m | 2,455,999 |  | Reduced −212,815 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $192.0m | 2,175,658 |  | Reduced −255,839 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $157.5m | 1,784,517 |  | Reduced −89,520 |
| [LONDON CO OF VIRGINIA](/funds/1259887.md) | 2026-06-30 | $123.5m | 1,399,101 |  | Reduced −77,537 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $119.0m | 1,348,671 |  | Reduced −73,548 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $115.6m | 1,309,435 |  | New +1,309,435 |
| [Holocene Advisors, LP](/funds/1700574.md) | 2026-06-30 | $110.1m | 1,247,073 |  | Reduced −519,569 |

## Recent filings

[All 2,553 filings](/companies/post/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 16:40 ET | [8-K](/filings/0001530950-26-000089.md) | 5.02 Departure or appointment of officers or directors; 5.05 Item not in the standard list | 0001530950-26-000089 |
| 2026-08-07 | 16:28 ET | [8-K/A](/filings/0001530950-26-000079.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001530950-26-000079 |
| 2026-08-06 | 16:23 ET | [10-Q](/filings/0001530950-26-000077.md) | Quarterly report, period 2026-06-30 | 0001530950-26-000077 |
| 2026-08-06 | 16:22 ET | [8-K](/filings/0001530950-26-000076.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001530950-26-000076 |
| 2026-05-07 | 16:24 ET | [10-Q](/filings/0001530950-26-000057.md) | Quarterly report, period 2026-03-31 | 0001530950-26-000057 |
| 2026-05-07 | 16:21 ET | [8-K](/filings/0001530950-26-000056.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001530950-26-000056 |
| 2026-03-13 | 16:17 ET | [8-K](/filings/0001530950-26-000041.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001530950-26-000041 |
| 2026-03-05 | 16:41 ET | [SCHEDULE 13D/A](/filings/0001052058-26-000003.md) | Ownership report, active investor, amended | 0001052058-26-000003 |
| 2026-03-04 | 16:17 ET | [8-K](/filings/0001530950-26-000038.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001530950-26-000038 |
| 2026-03-04 | 07:26 ET | [8-K](/filings/0001530950-26-000034.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001530950-26-000034 |

## Latest annual report

[Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001530950-25-000260.md), filed Nov 21, 2025.

## Forecast league

Q4 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/435d1374-f44a-41ff-aed8-2df359bd6c63)

## About the filer

- CIK: 1530950
- Tickers: POST
- Exchange: NYSE
- SIC code: 2040 Grain Mill Products
- State of incorporation: MO
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:47 ET. No prices; not investment advice.
